Wasting little time in harvesting the fruits of a hard-won recommendation-to-approve vote by the FDA circulatory systems advisory panel last month, <B>CryoCor</B> (San Diego) reported a development deal the with <B>Boston Scientific</B> (Natick, Massachusetts) the day after that panel decision.